活动性肝炎

慢性活动性肝炎和肝硬化患者以OKT3+细胞为主，而慢性迁延性肝炎时OKT3+细胞相对较少，本研究提示；

In CAH and cirrhosis , OKT3 + cell dominated , while in CPH , these cells were relatively scanty .

血清透明质酸可作为慢性活动性肝炎和早期肝硬化的预测指标。

The serum hyaluronic acid can be used as a predictive indicator to diagnose CAH and early liver cirrhosis .

前列腺E1对重型慢性活动性肝炎血浆脂质过氧化物水平的影响

Effects of Prostaglandin E_1 on Plasma Lipid Peroxides Level in Patients with Severe Chronic Active Viral Hepatitis

慢性活动性肝炎、肝硬化患者HBV与HCV的合并感染及其意义

Co-Infection of HBV and HCV in Chronic Active Hepatitis and Liven Cirrhosis Patients

血清HBsAg阴性和HBsAg阳性慢性活动性肝炎患者肝内HBVdna的研究

A study on HBV DNA in patients with serum HBsAg-negative and positive chronic active hepatitis

慢性活动性肝炎并HBV相关性肾炎发病率高，用激素及干扰素配合治疗效果好。

There is a high incidence of HBV associated GN among patients with chronic active hepatitis .

放免法检测乙型慢性活动性肝炎病人红细胞C（3b）受体的研究

Research on C3b Receptors on Erythrocytes from Patients wit Type B Chronic Active Hepatitis

慢性活动性肝炎17例、肝硬化21例和健康志愿者20例外周血均未检测到AFPmRNA的表达。

AFP mRNA was not detected in 17 chronic hepatitis , 21 cirrhosis and 20 normal healthy volunteers .

乙型慢性活动性肝炎的血清HBV-DNA动态变化与临床转归

A Study on the Prognostic Significance of Serum HBV-DNA Changes in Chronic Active Hepatitis B

目的观察前列腺素E1对活动性肝炎肝硬化的抗纤维化疗效。

Objective To study the efficacy of prostaglandin E1 ( PEG1 ) for antifibrosis on active hepatic cirrhosis .

乙型慢性活动性肝炎血清微量元素与肝功和HBeAg关系的研究

Study on the relationship between trace elements and liver function , HBeAg in patients with chronic active hepatitis B

方法口服拉米夫定100mg，每日一次，连服18个月治疗活动性肝炎肝硬化患者58例。

Methods 58 patients received lamivudine 100 mg orally everyday for 18 months .

方法；采用realtimeRT-PCR技术，定量检测肝细胞癌56例、慢性活动性肝炎17例、肝硬化21例和健康志愿者20例外周血AFPmRNA的表达水平。

Methods : Real time RT-PCR was used to detect AFP mRNA expression in peripheral blood from 56 patients with HCC , 17 with chronic hepatitis , 21 with cirrhosis and 20 normal healthy volunteers .

方法：56例慢性活动性肝炎（CAH）患者分为治疗组和对照组，治疗组患者接受干扰素抗病毒治疗，对照组仅做一般护肝治疗，然后测定Pre-S1相对滴度和HBVDN含量进行分析。

Methods : 56 chronic active hepatitis patients divide to therapy group and control group .

以放射免疫法测定了14例慢性活动性肝炎（CAH）和6例肝硬化（Cir）患者的血清Ⅲ型前胶原肽（PⅢP）水平。

The levels of serum P ⅲ P were measured in 14 patients with chronic active hepatitis ( CAH ) and 6 patients with liver cirrhosis ( Cir ) .

慢性活动性肝炎、慢性迁延性肝炎、重症肝炎IIPC均显著降低（P＜0.001）；

All the chronic active hepatitis ( CAH ), chronic persistent hepatitis ( CPH ) and severe hepatitis ( SH ) were markedly decreased ( P 0 . 001 );

方法：静脉注射复方甘草酸苷60mL，每日1次，连用18个月治疗活动性肝炎肝硬化患者58例。

Method : 58 patients received Compound Glycyrrhizin 60mL orally everyday for 18 months .

α干扰素（IFNα）是治疗活动性肝炎的主宰药物，单核苷酸类药物（lamivudine和adefovir）也具有同样的疗效。

Interferon alfa has been the mainstay of treatment for patients with active disease but nucleoside analogues ( lamivudine and adefovir ) are now available with similar efficacy .

本文对7例小儿慢性活动性肝炎（CAH）治疗前后2次肝穿刺标本作了光镜和电镜的对比观察。

Liver puncture biopsies of 7 cases of chronic active hepatitis ( CAH ) of children were examined by light and electron-microscopy .

在经肝活检诊断的慢性乙型活动性肝炎，两者的检出率在病情增重期显著高于缓解期，并高于肝组织正常的无症状HBV携带者。

In biopsy-proven chronic active hepatitis ( CAH ) B , prevalence of both tests were significantly higher at exacerbation than at remission of the disease , and so were in CAH than in chronic asymptomatic HBV carrier with normal histology .

结果表明血清中CG含量是肝功能受损的特异性指标，其灵敏度明显高于各单项常规肝功能检查，对慢性活动性肝炎与迁延性肝炎的鉴别诊断也有一定价值。

The results expressed that serum CG content is a high specificity and sensitivity indicator for liver function , and has certain value for differential diagnosis of chronic active hepatitis and chronic persistent hepatitis .

方法对e抗体阳性14例无症状携带（AsC）者及e抗体阳性14例慢性活动性肝炎（CAH）患者的血清HBVx及前C/C基因序列进行克隆、测序。

Methods The nucleotide sequences of X and precore / core genes of serum HBV were cloned and sequenced in 14 asymptomatic carriers ( AsCs ) and 14 chronic active hepatitis ( CAH ) patients with antibody against hepatitis B e antigen .

然而慢性持续性肝炎组、慢性活动性肝炎组及亚急性重型肝炎组门管区内FN含量与正常肝组比较均有所增多。

On the contrary , however , the FN content in portal triads in the chronic persistent hepatitis , chronic active hepatitis and subacute severe hepatitis groups increased in comparison with that of the normal liver group .

报告多重感染的慢性活动性肝炎（CAH）14例，占同期入院CAH总数的5.9%。

Fourteen cases with multiple infections of chronic active hepatitis ( CAH ) were reported , which accounted for 5 . 9 % of total inpatients with CAH in the same period .

结论儿童白血病继发HCV感染率高，但感染后多未呈进行性活动性肝炎表现，也未见肝功能失代偿发生；化疗期间HCVRNA检测优于HCVCP。

Conclusion In this study , the prevalence of HCV infection was high in patients who had been treated for a childhood acute leukemia , but there was neither progressive active hepatitis manifestation nor severe liver impairment after infection , while during chemotherapy HCV - RNA was better than HCV-CP.

本文通过对76例HBsAg阳性者HBV血清学标记进行41/2年随访，发现了慢性迁延性肝炎（CPH）和慢性活动性肝炎（CAH）备1例。半年后复查时阴转率为40.8%；

76 HBsAg positive patients were followed up for 45 months in the way of HBV serological marker and a CPH and a CAH were found among them 31 cases ( 40.8 % ) of them changed into HBsAg negative 6 months later .

结果40例非乙肝患者血清前S1蛋白全部阴性。138例乙肝患者中前S1蛋白的阳性率为31.2%，其中急性肝炎为91.1%，慢性活动性肝炎为52.1%；

Results In 40 patients without hepatitis B , serological test was negative for pre-S_1 protein and in 138 patients with hepatitis B , the overall positive rate of pre-S_1 protein was 31.2 % ( 91.1 % for acute hepatitis B and 52.1 % for chronic active hepatitis ) .

结论在慢性活动性肝炎、晚期肝硬化以及肝癌患者存在严重的MMP1和TIMP1的失平衡，这种失平衡是这些患者肝脏细胞外基质净沉积的重要原因。

Conclusions There is altered balance between MMP 1 and TIMP 1 in patients with chronic active hepatitis , liver cirrhosis and HCC , which is the reason for the net accumulation of extra cellular matrix in the livers of these patients .

慢性活动性肝炎多重感染&附14例分析

Multiple Infections in Chronic Active Hepatitis & Analysis of 14 Cases

肝炎肝硬化分型论治浅析慢性活动性肝炎临床病理分型探讨

An Approach to Clinical and Pathological Classification of Chronic Active Hepatitis